Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis

Abstract

We herein describe the case of a 65-year-old man with frequent hospitalizations for severe anemia due to several recurrent bleedings of a cutaneous metastasis of hepatocellular carcinoma, and its successful off label treatment with thalidomide therapy for controlling bleeding and reducing transfusion requirements.